-
MS Treatment Demonstrates Sustained Efficacy and Safety
Post-hoc analyses from the CLARITY extension trial show that Mavenclad continues to demonstrate sustained efficacy and safety in patients with relapsing MS. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.